Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CRF ELISA Kit (AC3802)
Cat.#: ASET-2391
Specifications
Description Human CRF ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of human CRF concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 1.4 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2.188-140 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1275 Rat GDF11 ELISA Kit (AC2686) Quantitative inquiry ASET-2158 Human GDNF ELISA Kit (AC3569) Quantitative inquiry ASET-2186 Human Calretinin ELISA Kit (AC3597) Quantitative inquiry ASET-2465 Human Syntaxin 1a ELISA Kit (AC3876) Quantitative inquiry ASET-2359 Mouse IL-6 ELISA Kit (AC3770) Quantitative inquiry ASET-1936 Human FADS2 ELISA Kit (AC3347) Quantitative inquiry ASET-1370 Mouse C3 ELISA Kit (AC2781) Quantitative inquiry ASET-2522 Human Nogo ELISA Kit (AC3933) Quantitative inquiry ASET-2425 Human DYRK1A ELISA Kit (AC3836) Quantitative inquiry ASET-2188 Human ProSAAS ELISA Kit (AC3599) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket